| 24.09 11:01 | dpa-AFX: Original-Research: Valneva (von First Berlin Equity Research GmbH): Kaufen |
| 24.09 11:01 | dpa-AFX: Original-Research: Valneva (von First Berlin Equity Research GmbH): Kaufen |
| 24.09 11:01 | Original-Research: Valneva (von First Berlin Equity Research GmbH): Kaufen |
| 24.09 11:01 | Original-Research: Valneva (von First Berlin Equity Research GmbH): Kaufen |
| 23.09 15:46 | Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy |
| 23.09 15:46 | dpa-AFX: Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy |
| 23.09 15:46 | dpa-AFX: Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy |
| 23.09 15:46 | Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy |
| 13.09 08:11 | dpa-AFX: *VALNEVA AUF TRADEGATE SEHR AKTIV MIT -9% - PRIVATPLATZIERUNG VON STAMMAKTIEN |
| 03.09 09:27 | dpa-AFX: *VALNEVA +3,7% - BRYAN GARNIER: 'POSITIVE ERGEBNISSE MIT BORRELIOSE-IMPFSTOFF' |
| 22.08 10:51 | Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy |
| 22.08 10:51 | dpa-AFX: Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy |
| 22.08 10:51 | dpa-AFX: Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy |
| 22.08 10:51 | Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy |
| 20.08 16:01 | Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy |
| 20.08 16:01 | dpa-AFX: Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy |
| 20.08 16:01 | dpa-AFX: Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy |
| 20.08 16:01 | Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy |
| 24.06 11:24 | dpa-AFX: *VALNEVA +7,2% - KANADISCHE GESUNDHEITSBEHÖRDE LÄSST IMPFSTOFF ZU |
| 18.04 16:01 | dpa-AFX: Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy |
|
|
